Skip to main content
. 2020 Feb 11;2020(2):CD004863. doi: 10.1002/14651858.CD004863.pub6

Avent 2002.

Methods Randomised open controlled study 
 Study location: 2 centres in South Africa 
 Study period: not stated
Participants 93 infants < 7 days of life, in room air or requiring 30% oxygen at study entry with birth weight between 900 and 1500 grams
 Infants were stratified by weight < 1250 grams and > 1250 grams, then were randomised to 3 treatment groups.
Interventions 32 infants (low‐dose group) received EPO (Recormon) SC, 250 IU/kg 3 times a week (high dose).
 31 infants (high‐dose group) received EPO (Recormon) SC, 400 IU/kg 3 times a week (high dose).
 30 infants (control group) received standard care.
 The endpoint of therapy was reached when the infant was discharged from the hospital.
 All infants received a therapeutic dose of 6 mg/kg (high dose) elemental iron orally every day; this was increased to 8 to 10 mg/kg (high‐dose iron) if hypochromic cells accounted for 20% or more.
 All infants subsequently received blood transfusions if they met the transfusion criteria.
Outcomes Use of 1 or more red blood cell transfusions
 Total volume (mL/kg) of blood transfused per infant
 Number of blood transfusions per infant
 Mortality
 Sepsis
 Hypertension
 Length of hospital stay
Notes It is not stated whether infants who had received blood transfusions before study entry were included. Transfusion guidelines were in place.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information provided
Allocation concealment (selection bias) Unclear risk Blinding of randomisation unclear
Blinding of participants and personnel (performance bias) 
 All outcomes High risk No placebo was given to the control group. Personnel were aware of treatments.
Blinding of outcome assessment (detection bias) 
 All outcomes High risk No placebo was given to the control group. Outcome assessors were aware of treatments.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Complete follow‐up: yes
Selective reporting (reporting bias) Unclear risk The protocol for the study was not available to us; therefore we cannot ascertain whether deviations from the protocol occurred.
Other bias Low risk Appears free of other bias